Ipca Laboratories
IPCALAB
Quick Bite
Price To Earnings Ratio 67.70 | Sector PE 62.71 |
PB Ratio 5.85 | Sector PB 8.93 |
EPS 21.57 | Dividend Yield 0.32 |
Today's Volume 332.239 K | 5 Day Avg. Volume 257.249 K |
PEG Ratio 4.20 | Market Cap. ₹ 37,500.00 Cr. |
Returns Comparison
| Time | IPCALAB | VS | Industry |
|---|---|---|---|
| 1 Day | 1.45% | -0.56% | |
| 1 Week | 1.41% | -0.91% | |
| 1 Month | 5.03% | -2.19% | |
| 6 Months | 8.93% | 20.91% | |
| 1 Year | 55.83% | 60.08% |
Technical Trend
Pivot Levels
Moving Averages
| Period (Days) | SMA | Indication |
|---|---|---|
| 10 | 1477.86 | Bearish |
| 20 | 1461.67 | Bearish |
| 30 | 1439.72 | Bullish |
| 50 | 1398.3 | Bullish |
| 100 | 1301.52 | Bullish |
| 200 | 1248.96 | Bullish |
News & Events
Shareholding Updates
Cash Flow
| Annual | FY 2024 | FY 2023 | FY 2022 | ||||
|---|---|---|---|---|---|---|---|
| Operating Activities | 944.65 | 805.81 | 856.07 | ||||
| Investing Activities | -1291.79 | -725.00 | -855.05 | ||||
| Financing Activities | -552.55 | 507.24 | 426.78 | ||||
| Net Cash Flow | -899.69 | 588.05 | 427.80 |
All Figures in ₹ Cr., unless mentioned otherwise
Ratios
Income Statement
Balance Sheet
Peer Comparison
| Name | 1D (%) | 1W (%) | 1M (%) | 6M (%) | 1Y (%) |
|---|---|---|---|---|---|
| Ipca Laboratories | 1.45 | 1.41 | 5.03 | 8.93 | 55.83 |
| Alembic | -1.29 | 1.37 | -9.62 | 5.12 | 5.12 |
| Aurobindo Pharma | 0.81 | -2.57 | -5.78 | 23.54 | 65.22 |
| Fortis Healthcare | -2.48 | -5.31 | 7.33 | 26.86 | 67.86 |
| Ajanta Pharmaceuticals | -1.65 | 5.57 | 2.58 | 34.4 | 90.22 |
About Ipca Laboratories
Ipca Laboratories Share Price
Ipca Laboratories Limited is an Indian pharmaceutical company. The company manufactures and markets more than 350 dosage forms and approximately 80 active ingredients (APIs) covering various therapeutic segments. It offers APIs such as atenolol, chloroquine phosphate, chlorthalidone, furosemide, hydroxychloroquine sulfate, losartan, metoprolol succinate, metoprolol tartrate, pyrantel salts and propranolol. The company offers brands such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The company's products are sold in more than 100 countries around the world. The company has 18 manufacturing facilities in India that manufacture APIs and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc., Ipca Laboratories (U.K.) Ltd and Tonira Exports Limited.
Ipca Laboratories FAQs
How to Buy Ipca Laboratories Share?
What's Ipca Laboratories share price today?
What is the Market Cap of Ipca Laboratories?
What is the PE and PB ratio of Ipca Laboratories?
What is the 52 Week High and Low of Ipca Laboratories Share?